DCGI gives nod to conduct study on mixing Covaxin, Covishield | India News

Spread the love

NEW DELHI: The Drugs Controller General of India (DCGI) has given approval to conduct a study on mixing Covaxin and Covishield vaccines.
The research study will be done by Christian Medical College, Vellore, said Dr V K Paul, Niti Aayog during a press briefing on Tuesday.
Earlier, the Indian Council of Medical Research (ICMR) had revealed in its study that the combination of Covaxin and Covishield vaccines, the two main vaccines of the Covid-19 vaccination programme, conducted on 18 people, has elicited better safety and immunogenicity results.
In the study, ICMR compared the safety and immunogenicity profile with those individuals who received either Covaxin or Covishield and it showed better results.
The nationwide vaccination program at this time had entered in its fourth month of its existence and the event of mixed dosing raised considerable anxiety in public domain with a potential to contributing to vaccine hesitancy.
The study was conducted against this backdrop.
So, including these 18 individuals who had received one dose of Covishield and second dose of Covaxin, 40 recipients of two doses of Covishield and 40 recipients of two doses of Covaxin, were recruited in the study. The study duration was from May to June 2021.
( With agency inputs)

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: